Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$486K Sell
4,067
-1,889
-32% -$248K 0.01% 623
2025
Q4
$811K Sell
5,956
-384
-6% -$55.2K 0.01% 433
2025
Q3
$935K Sell
6,340
-2
-0% -$277 0.01% 398
2025
Q2
$820K Buy
6,342
+441
+7% +$53.4K 0.01% 407
2025
Q1
$705K Buy
5,901
+832
+16% +$103K 0.01% 428
2024
Q4
$588K Buy
5,069
+59
+1% +$7.46K 0.01% 473
2024
Q3
$677K Buy
5,010
+720
+17% +$96.3K 0.01% 435
2024
Q2
$582K Sell
4,290
-30
-0.7% -$4.08K 0.01% 454
2024
Q1
$558K Buy
4,320
+9
+0.2% +$1.09K 0.01% 472
2023
Q4
$493K Sell
4,311
-110
-2% -$11K 0.01% 476
2023
Q3
$402K Sell
4,421
-273
-6% -$28.2K 0.01% 513
2023
Q2
$529K Buy
4,694
+137
+3% +$14.5K 0.01% 423
2023
Q1
$477K Sell
4,557
-186
-4% -$19.4K 0.01% 453
2022
Q4
$524K Sell
4,743
-172
-3% -$18K 0.02% 401
2022
Q3
$429K Buy
4,915
+2,203
+81% +$200K 0.01% 429
2022
Q2
$212K Buy
2,712
+404
+18% +$33.4K 0.01% 679
2022
Q1
$197K Buy
2,308
+866
+60% +$83K 0.01% 719
2021
Q4
$173K Sell
1,442
-66
-4% -$8.19K 0.01% 779
2021
Q3
$187K Buy
1,508
+256
+20% +$32.9K 0.01% 721
2021
Q2
$150K Buy
1,252
+281
+29% +$32.1K 0.01% 789
2021
Q1
$102K Buy
971
+620
+177% +$62.9K ﹤0.01% 873
2020
Q4
$36K Buy
351
+27
+8% +$2.54K ﹤0.01% 1231
2020
Q3
$27K Sell
324
-33
-9% -$2.57K ﹤0.01% 1246
2020
Q2
$23K Sell
357
-207
-37% -$13.7K ﹤0.01% 1292
2020
Q1
$37K Buy
564
+212
+60% +$16.7K ﹤0.01% 1009
2019
Q4
$28K Buy
352
+60
+21% +$4.67K ﹤0.01% 1170
2019
Q3
$23K Buy
292
+19
+7% +$1.49K ﹤0.01% 1178
2019
Q2
$23K Hold
273
﹤0.01% 1159
2019
Q1
$22K Sell
273
-16
-6% -$1.17K ﹤0.01% 1160
2018
Q4
$19K Buy
289
+69
+31% +$4.77K ﹤0.01% 1167
2018
Q3
$18K Hold
220
﹤0.01% 1206
2018
Q2
$15K Hold
220
﹤0.01% 1276
2018
Q1
$17K Buy
+220
New +$16.3K ﹤0.01% 1097
2016
Q4
Sell
-205
Closed -$11K 1264
2016
Q3
$11K Buy
205
+72
+54% +$3.53K ﹤0.01% 999
2016
Q2
$6K Buy
133
+96
+259% +$4.17K ﹤0.01% 1061
2016
Q1
$2K Buy
+37
New +$1.36K ﹤0.01% 1195

Other funds holding XYL

SignatureFD's XYL Position: Q1 2026 in Review

SignatureFD reduced its Xylem (XYL) stake by 32% in Q1 2026, selling an estimated $248K and leaving 4,067 shares worth $486K. The position accounts for 0.01% of the portfolio, ranked #623.

SignatureFD first reported a position in XYL in Q1 2016 and has held it in 36 quarters since. The position peaked at $935K in Q3 2025. 1,107 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • SignatureFD held 4,067 shares of Xylem worth $486K as of Q1 2026.
  • SignatureFD sold 1,889 Xylem shares in Q1 2026, an estimated $248K.
  • Xylem made up 0.01% of SignatureFD's portfolio in Q1 2026, its #623 holding.
  • SignatureFD first reported a position in Xylem in Q1 2016 and has held it in 36 quarters since.
  • SignatureFD's Xylem position peaked at $935K in Q3 2025.
  • 1,107 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.